These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 29149502)
1. Annual banned-substance review: Analytical approaches in human sports drug testing. Thevis M; Kuuranne T; Geyer H Drug Test Anal; 2018 Jan; 10(1):9-27. PubMed ID: 29149502 [TBL] [Abstract][Full Text] [Related]
2. Annual banned-substance review: Analytical approaches in human sports drug testing. Thevis M; Kuuranne T; Geyer H Drug Test Anal; 2019 Jan; 11(1):8-26. PubMed ID: 30488582 [TBL] [Abstract][Full Text] [Related]
3. Annual banned-substance review - Analytical approaches in human sports drug testing. Thevis M; Kuuranne T; Geyer H Drug Test Anal; 2020 Jan; 12(1):7-26. PubMed ID: 31724288 [TBL] [Abstract][Full Text] [Related]
4. Annual banned-substance review: analytical approaches in human sports drug testing. Thevis M; Kuuranne T; Geyer H; Schänzer W Drug Test Anal; 2017 Jan; 9(1):6-29. PubMed ID: 27885819 [TBL] [Abstract][Full Text] [Related]
5. Annual banned-substance review: analytical approaches in human sports drug testing. Thevis M; Kuuranne T; Geyer H; Schänzer W Drug Test Anal; 2013 Jan; 5(1):1-19. PubMed ID: 23229872 [TBL] [Abstract][Full Text] [Related]
6. Annual banned-substance review: Analytical approaches in human sports drug testing 2020/2021. Thevis M; Kuuranne T; Geyer H Drug Test Anal; 2022 Jan; 14(1):7-30. PubMed ID: 34788500 [TBL] [Abstract][Full Text] [Related]
7. Annual banned-substance review: analytical approaches in human sports drug testing. Thevis M; Kuuranne T; Geyer H; Schänzer W Drug Test Anal; 2012 Jan; 4(1):2-16. PubMed ID: 22287289 [TBL] [Abstract][Full Text] [Related]
8. Annual banned-substance review: analytical approaches in human sports drug testing. Thevis M; Kuuranne T; Geyer H; Schänzer W Drug Test Anal; 2011 Jan; 3(1):1-14. PubMed ID: 21254451 [TBL] [Abstract][Full Text] [Related]
9. Annual banned-substance review: Analytical approaches in human sports drug testing 2019/2020. Thevis M; Kuuranne T; Geyer H Drug Test Anal; 2021 Jan; 13(1):8-35. PubMed ID: 33185038 [TBL] [Abstract][Full Text] [Related]
10. Annual banned-substance review: analytical approaches in human sports drug testing. Thevis M; Kuuranne T; Geyer H; Schänzer W Drug Test Anal; 2015 Jan; 7(1):1-20. PubMed ID: 25545248 [TBL] [Abstract][Full Text] [Related]
11. Annual banned-substance review: analytical approaches in human sports drug testing. Thevis M; Kuuranne T; Geyer H; Schänzer W Drug Test Anal; 2014; 6(1-2):164-84. PubMed ID: 24285613 [TBL] [Abstract][Full Text] [Related]
12. Sports drug testing using complementary matrices: Advantages and limitations. Thevis M; Geyer H; Tretzel L; Schänzer W J Pharm Biomed Anal; 2016 Oct; 130():220-230. PubMed ID: 27040951 [TBL] [Abstract][Full Text] [Related]
13. Annual banned-substance review-Analytical approaches in human sports drug testing 2021/2022. Thevis M; Kuuranne T; Geyer H Drug Test Anal; 2023 Jan; 15(1):5-26. PubMed ID: 36369629 [TBL] [Abstract][Full Text] [Related]
14. Annual banned-substance review: analytical approaches in human sports drug testing. Thevis M; Kuuranne T; Walpurgis K; Geyer H; Schänzer W Drug Test Anal; 2016 Jan; 8(1):7-29. PubMed ID: 26767774 [TBL] [Abstract][Full Text] [Related]
15. Annual banned-substance review 16 Thevis M; Kuuranne T; Geyer H Drug Test Anal; 2024 Jan; 16(1):5-29. PubMed ID: 37985429 [TBL] [Abstract][Full Text] [Related]
16. Investigating the use of stimulants in out-of-competition sport samples. Boghosian T; Mazzoni I; Barroso O; Rabin O J Anal Toxicol; 2011 Nov; 35(9):613-6. PubMed ID: 22080900 [TBL] [Abstract][Full Text] [Related]
17. Structure and Development of the List of Prohibited Substances and Methods. Kinahan A; Budgett R; Mazzoni I Med Sport Sci; 2017; 62():39-54. PubMed ID: 28571027 [TBL] [Abstract][Full Text] [Related]
18. Annual banned-substance review: analytical approaches in human sports drug testing. Thevis M; Kuuranne T; Geyer H; Schänzer W Drug Test Anal; 2010 Apr; 2(4):149-61. PubMed ID: 20376830 [TBL] [Abstract][Full Text] [Related]
19. Treating the elite athlete: anti-doping information for the health professional. Tandon S; Bowers LD; Fedoruk MN Mo Med; 2015; 112(2):122-8. PubMed ID: 25958657 [TBL] [Abstract][Full Text] [Related]
20. Measurement uncertainty in anti-doping quantitative analysis for prohibited threshold substances. Barroso O; Miller J; Squirrell A; Westwood S Bioanalysis; 2012 Jul; 4(13):1653-65. PubMed ID: 22831481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]